Filter
181 - 190 of 1073 results
Results for
Raising a Voice for Benin’s Private Health Sector
Impact Brief
With Abt and USG guidance, Benin’s Private Health Sector Platform advocates for the private sector’s role in helping reduce maternal and child mortality.
Association of Medicare's Bundled Payments for Care Improvement initiative with patient‐reported outcomes
Publication
Impact of the Comprehensive Care for Joint Replacement Model on Patient Reported Outcomes
Publication
An Abt study in Health Services Research found the CJR model didn’t harm patients’ health, but they were slightly more likely to rely on caregivers for recovery.
Explaining the Impact of USDA's Healthy Incentives Pilot on Different Spending Outcomes
Publication
Making the Most of a Preschool Expansion Grant (PEG)
Project
In late 2014, the Massachusetts Department of Early Education and Care (EEC) was awarded a federal Preschool Expansion Grant (PEG) to expand high-quality early childhood education to more than 800 4-year-old children per year in five underserved…
Improving Access, Quality, and Delivery of Behavioral Health Care
Project
Communities continue to face challenges accessing quality behavioral health care and services. Abt helps SAMHSA advance behavioral health excellence
Evaluating the Employment Transition Model Demonstration
Project
Low-income youth and young adults with disabilities (Y&YAD) face a myriad of unique and challenging obstacles to improving their economic well-being, from experiencing homelessness to involvement in the foster care system...
Evaluating Ryan White HIV/AIDS Program Care Models
Project
The Ryan White HIV/AIDS Program (RWHAP), administered by the Health Resources and Services Administration (HRSA) within the Department of Health and Human Services, provides a comprehensive system of care for people living with HIV and AIDS. Although…
Evaluating the Cell and Gene Therapy Access Model
Project
The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies.